- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsing-Remitting Multiple Sclerosis (RRMS) in United Kingdom
Total 1446 results
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
LAPIX Therapeutics Inc.CompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, United Kingdom, Australia, Netherlands, Ireland, Norway, Turkey, Estonia, Denmark, Germany, Italy, Spain, Switzerland, France, Finland, Sweden, Czechia
-
Cionic, Inc.RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenElan PharmaceuticalsCompleted
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingSpain, Germany, Croatia, Turkey, Saudi Arabia, Hungary, Belgium, Australia, France, Portugal, Slovakia, United States, Bulgaria, Greece, Kuwait, Russian Federation, Tunisia, Italy, Argentina, Czechia, Israel, Serbia
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Belgium, Turkey, Bulgaria, United States, Czechia, Germany, Kuwait, Latvia, Lebanon
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingPoland, Turkey, United States, Latvia, Lebanon, Germany, Belgium, Bulgaria, Czechia, Kuwait
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingCanada, United States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom, Australia, Belgium, Brazil, Croatia, France, Canada, Slovakia, Germany, Netherlands, Norway, Italy, Poland, Switzerland, Romania, Bulgaria, Spain, Mexico, Austria, Portugal, Turkey, Sweden, Argentina, Denmark and more
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
TG Therapeutics, Inc.CompletedRelapsing Multiple Sclerosis (RMS)United States
-
Shirley Ryan AbilityLabNorthwestern UniversityNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
BiogenCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Bulgaria, Belgium, Poland, Lithuania, Kuwait, Turkey
-
CelgeneCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Germany
-
MallinckrodtMallinckrodt ARD Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingMexico, Turkey, United States, Hungary, Taiwan, Thailand, Korea, Republic of, Saudi Arabia, Malaysia, Colombia, Estonia, Jordan, Tunisia
-
Mallinckrodt ARD LLCTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Abu Dhabi Stem Cells CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited Arab Emirates
-
Mapi Pharma Ltd.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Estonia, Georgia, Israel, Moldova, Republic of, Russian Federation, Ukraine
-
Bristol-Myers SquibbActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Providence Health & ServicesMallinckrodtCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, United States, Canada, France, Switzerland, Ireland, Italy, Australia, Spain, Austria, Germany, Brazil, Netherlands, Poland, Russian Federation, Hungary, Slovenia, Argentina, Ukraine, Greece, Sweden, Finland, Latvia, No... and more
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
TG Therapeutics, Inc.Active, not recruitingRelapsing Multiple Sclerosis (RMS)United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
Terry L. WahlsNational Multiple Sclerosis SocietyActive, not recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Shirley Ryan AbilityLabNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis-Relapsing-RemittingUnited States
-
Shirley Ryan AbilityLabEdward Hines Jr. VA HospitalCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Terry L. WahlsRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Opexa Therapeutics, Inc.TerminatedClinically Isolated Syndrome | Multiple Sclerosis, Relapsing-RemittingUnited States
-
EMD SeronoTerminated
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
George Washington UniversityCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden